Multi-Stage Energy Conversion in Covalent Organic Frameworks for Electrogenesis Boosted Immunotherapy
- PMID: 40801172
- DOI: 10.1002/smll.202504883
Multi-Stage Energy Conversion in Covalent Organic Frameworks for Electrogenesis Boosted Immunotherapy
Abstract
Electrical energy enables tumor therapy by generating reactive oxygen species (ROS); however, its clinical translation remains hindered by the reliance on external electrodes and the biocompatibility challenges of inorganic sensitizers. Here, covalent organic frameworks (COFs)-based energy-conversion platform termed as Py-ttTII@PEG, is engineered for non-invasive photo-triggered electrocatalysis augmented immunotherapy. The donor-acceptor-donor (D-A-D) building block, composed of electron-rich thienoisoindigo, electron-deficient thienothiophene, and tetradentate counterpart, pyrene tetraaniline (Py(NH2)4), is used to construct Py-ttTII@PEG. Under NIR-II laser irradiation, Py-ttTII@PEG NPs (nanoparticles) produce heat to ablate tumors, and multiple reactive oxygen species via triggered electrocatalysis to damage heat shock proteins and augment the therapeutic effect. Significantly, the cascade effects activate robust immunogenic cell death. In vivo studies reveal its potent anti-tumor effectiveness and the stimulation of an effective immune response under NIR-II laser irradiation, which suppresses the progression of distant tumors and lung metastasis. Additionally, RNA sequencing analysis indicate that Py-ttTII@PEG NPs induce the activation of immune-related pathways and the enrichment of regulatory genes in cell death- and immune-related pathways under NIR-II laser exposure. Thus, this work provides a feasible strategy by tightly coupling energy conversion to establishes an in vivo pyroelectricity generator for improving the therapeutic efficacy of immunotherapy against tumor metastasis.
Keywords: covalent organic frameworks; immunogenic cell death; photo‐triggered electrogenesis; reactive oxygen species; tumor therapy.
© 2025 Wiley‐VCH GmbH.
Similar articles
-
Phenanthroline-functionalized donor-acceptor covalent organic frameworks as photo-responsive nanozymes for visual colorimetric detection of isoniazid.J Mater Chem B. 2024 May 8;12(18):4502-4508. doi: 10.1039/d3tb02939e. J Mater Chem B. 2024. PMID: 38646996
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
A Co-catalytic nanosystem based on molybdenum disulfide and Prussian blue for synergistic chemodynamic and photothermal therapy through mitochondrial damage and ferroptosis.Acta Biomater. 2025 Jul 23:S1742-7061(25)00534-3. doi: 10.1016/j.actbio.2025.07.037. Online ahead of print. Acta Biomater. 2025. PMID: 40712728
-
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025. Front Immunol. 2025. PMID: 40777041 Free PMC article.
-
Systemic treatments for metastatic cutaneous melanoma.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article.
References
-
- C. Xu, X. Qin, X. Wei, J. Yu, Y. Zhang, Y. Zhang, D. Ding, J. Song, K. Pu, Nat. Nanotechnol. 2025, 20, 286.
-
- G. Chen, Q. Xu, Z. Feng, Q. Xu, X. Zhang, Y. Yang, Y. Zhang, X.‐J. Liang, Z. Yu, M. Yu, ACS Nano 2022, 16, 951.
-
- D. Li, E. Ha, Z. Zhou, J. Zhang, Y. Zhu, F. Ai, L. Yan, S. He, L. Li, J. Hu, Adv. Mater. 2024, 36, 2308747.
-
- Y. Kong, F. Liu, B. Ma, J. Duan, W. Yuan, Y. Sang, L. Han, S. Wang, H. Liu, Adv. Sci. 2021, 8, 2100962.
-
- W. Liu, N. Wu, J. Song, L. Xie, J. Zhang, J. Liu, A. Dong, Chem. Eng. J. 2024, 494, 152882.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous